{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20200707",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1/4",
          "submission_class_code_description": "Type 1 - New Molecular Entity and Type 4 - New Combination",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "63820",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212576s000lbl.pdf",
              "date": "20200707",
              "type": "Label"
            },
            {
              "id": "63821",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/212576Orig1s000ltr.pdf",
              "date": "20200708",
              "type": "Letter"
            },
            {
              "id": "64100",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/212576Orig1s000TOC.html",
              "date": "20200727",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20220324",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "70603",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/212576Orig1s003ltr.pdf",
              "date": "20220325",
              "type": "Letter"
            },
            {
              "id": "70609",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212576s003lbl.pdf",
              "date": "20220325",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20260513",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "85918",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/212576Orig1s008ltr.pdf",
              "date": "20260515",
              "type": "Letter"
            },
            {
              "id": "85926",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/0212576s008lbl.pdf",
              "date": "20260518",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA212576",
      "sponsor_name": "TAIHO ONCOLOGY",
      "openfda": {
        "application_number": [
          "NDA212576"
        ],
        "brand_name": [
          "INQOVI"
        ],
        "generic_name": [
          "CEDAZURIDINE AND DECITABINE"
        ],
        "manufacturer_name": [
          "Taiho Pharmaceutical Co., Ltd."
        ],
        "product_ndc": [
          "64842-0727"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "CEDAZURIDINE",
          "DECITABINE"
        ],
        "rxcui": [
          "2384457",
          "2384458",
          "2384464",
          "2384465"
        ],
        "spl_id": [
          "12a04358-38a6-4d9d-965b-de70660f9ed0"
        ],
        "spl_set_id": [
          "91a0f80b-f865-4d06-a40d-4d148d99ee71"
        ],
        "package_ndc": [
          "64842-0727-9"
        ],
        "nui": [
          "N0000000233",
          "N0000175595"
        ],
        "pharm_class_moa": [
          "Nucleic Acid Synthesis Inhibitors [MoA]"
        ],
        "pharm_class_epc": [
          "Nucleoside Metabolic Inhibitor [EPC]"
        ],
        "unii": [
          "39IS23Q1EW",
          "776B62CQ27"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "INQOVI",
          "active_ingredients": [
            {
              "name": "CEDAZURIDINE",
              "strength": "100MG"
            },
            {
              "name": "DECITABINE",
              "strength": "35MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}